Long covid: cross sectional study
Introduction: Coronavirus disease 2019 (COVID-19) is a public health problem worldwide. After 3 weeks of the onset of the disease, between 10-87% of patients persist with symptoms. The objective of the study was to evaluate the persistence of symptoms in patients with COVID-19, the associated factor...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artículo revista |
| Lenguaje: | Español |
| Publicado: |
Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
2021
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/med/article/view/32048 |
| Aporte de: |
| id |
I10-R10-article-32048 |
|---|---|
| record_format |
ojs |
| institution |
Universidad Nacional de Córdoba |
| institution_str |
I-10 |
| repository_str |
R-10 |
| container_title_str |
Revistas de la UNC |
| language |
Español |
| format |
Artículo revista |
| topic |
COVID-19 SARS-CoV-2 symptoms fatigue follow up studies COVID-19 SARS-CoV-2 síntomas fatiga estudios de seguimiento COVID-19 SARS-CoV-2 síntomas fadiga seguimentos |
| spellingShingle |
COVID-19 SARS-CoV-2 symptoms fatigue follow up studies COVID-19 SARS-CoV-2 síntomas fatiga estudios de seguimiento COVID-19 SARS-CoV-2 síntomas fadiga seguimentos Prieto, Manuel Antonio Prieto, Omar Castro, Horacio Matias Long covid: cross sectional study |
| topic_facet |
COVID-19 SARS-CoV-2 symptoms fatigue follow up studies COVID-19 SARS-CoV-2 síntomas fatiga estudios de seguimiento COVID-19 SARS-CoV-2 síntomas fadiga seguimentos |
| author |
Prieto, Manuel Antonio Prieto, Omar Castro, Horacio Matias |
| author_facet |
Prieto, Manuel Antonio Prieto, Omar Castro, Horacio Matias |
| author_sort |
Prieto, Manuel Antonio |
| title |
Long covid: cross sectional study |
| title_short |
Long covid: cross sectional study |
| title_full |
Long covid: cross sectional study |
| title_fullStr |
Long covid: cross sectional study |
| title_full_unstemmed |
Long covid: cross sectional study |
| title_sort |
long covid: cross sectional study |
| description |
Introduction: Coronavirus disease 2019 (COVID-19) is a public health problem worldwide. After 3 weeks of the onset of the disease, between 10-87% of patients persist with symptoms. The objective of the study was to evaluate the persistence of symptoms in patients with COVID-19, the associated factors, and to explore the patients' perception of the disease.
Materials and methods: We conducted a cross-sectional study that included 85 patients with a confirmed diagnosis of COVID-19, who attended on an outpatient basis after the acute phase (> 3 weeks) of the disease.
Results: The median time from diagnosis to outpatient consultation was 53 days (interquartile range 31-65). Most (86%) had mild disease, 45% were women and the mean age was 43 years (standard deviation of 13). After the acute phase of the disease 52% (95% CI 41-63%) of the patients persisted with symptoms. The most frequently persistent symptoms were fatigue (49%) and cough (33%). Nineteen percent had insomnia and sixteen percent had anxiety. Female sex, obesity, age between 35-55 years, and initial hospitalization were associated with the persistence of symptoms. Twenty percent of the patients stopped following the prevention recommendations because they believed they were immunized.
Conclusion: More than half of the patients persisted with symptoms 3 weeks after the COVID-19 diagnosis, so medical follow-up is important. Female sex, obesity, age 35-55 years, and initial hospitalization were associated factors. The symptoms usually resolved over time. |
| publisher |
Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología |
| publishDate |
2021 |
| url |
https://revistas.unc.edu.ar/index.php/med/article/view/32048 |
| work_keys_str_mv |
AT prietomanuelantonio longcovidcrosssectionalstudy AT prietoomar longcovidcrosssectionalstudy AT castrohoraciomatias longcovidcrosssectionalstudy AT prietomanuelantonio covidprolongadoestudiodecortetransversal AT prietoomar covidprolongadoestudiodecortetransversal AT castrohoraciomatias covidprolongadoestudiodecortetransversal AT prietomanuelantonio covidlongoestudotransversal AT prietoomar covidlongoestudotransversal AT castrohoraciomatias covidlongoestudotransversal |
| first_indexed |
2022-08-20T01:27:41Z |
| last_indexed |
2022-08-20T01:27:41Z |
| _version_ |
1770719088503422976 |
| spelling |
I10-R10-article-320482021-07-07T13:29:31Z Long covid: cross sectional study Covid prolongado: estudio de corte transversal Covid longo: estudo transversal Prieto, Manuel Antonio Prieto, Omar Castro, Horacio Matias COVID-19 SARS-CoV-2 symptoms fatigue follow up studies COVID-19 SARS-CoV-2 síntomas fatiga estudios de seguimiento COVID-19 SARS-CoV-2 síntomas fadiga seguimentos Introduction: Coronavirus disease 2019 (COVID-19) is a public health problem worldwide. After 3 weeks of the onset of the disease, between 10-87% of patients persist with symptoms. The objective of the study was to evaluate the persistence of symptoms in patients with COVID-19, the associated factors, and to explore the patients' perception of the disease. Materials and methods: We conducted a cross-sectional study that included 85 patients with a confirmed diagnosis of COVID-19, who attended on an outpatient basis after the acute phase (> 3 weeks) of the disease. Results: The median time from diagnosis to outpatient consultation was 53 days (interquartile range 31-65). Most (86%) had mild disease, 45% were women and the mean age was 43 years (standard deviation of 13). After the acute phase of the disease 52% (95% CI 41-63%) of the patients persisted with symptoms. The most frequently persistent symptoms were fatigue (49%) and cough (33%). Nineteen percent had insomnia and sixteen percent had anxiety. Female sex, obesity, age between 35-55 years, and initial hospitalization were associated with the persistence of symptoms. Twenty percent of the patients stopped following the prevention recommendations because they believed they were immunized. Conclusion: More than half of the patients persisted with symptoms 3 weeks after the COVID-19 diagnosis, so medical follow-up is important. Female sex, obesity, age 35-55 years, and initial hospitalization were associated factors. The symptoms usually resolved over time. Introducción: La enfermedad por Coronavirus 2019 (COVID-19) es un problema de salud pública a nivel mundial. Posterior a las 3 semanas de iniciado el cuadro entre un 10-87% de los pacientes persisten con síntomas. El objetivo del estudio fue evaluar la persistencia de los síntomas en pacientes que presentaron la COVID-19, los factores asociados y explorar la percepción de los pacientes sobre la enfermedad. Materiales y Métodos: Se realizó un estudio de corte transversal que incluyó 85 pacientes con diagnóstico confirmado de COVID-19, que consultaron en forma ambulatoria posterior a la fase aguda (> 3 semanas) de la enfermedad. Resultados: La mediana de tiempo desde el diagnóstico a la consulta ambulatoria fue de 53 días (rango inter cuartil 31-65). La mayoría (86%) presentó un cuadro leve y no requirió internación. El 45% eran mujeres y la media de edad fue de 43 años (desvío estándar de 13). El 52% (IC95% 41-63%) de los pacientes persistían con síntomas más allá de la fase aguda de la enfermedad. El síntoma que persistió con más frecuencia fue la fatiga (49%) seguida de la tos (33%). El 19% presentó insomnio y el 16% tenía ansiedad. El sexo femenino, la obesidad, la edad entre 35-55 años y la hospitalización inicial, se asociaron a la persistencia de los síntomas. Un 20% de los pacientes dejó de seguir las recomendaciones de prevención porque creía estar inmunizado. Conclusión: Más de la mitad de los pacientes persistían con síntomas posterior a las 3 semanas del diagnóstico de COVID-19. El sexo femenino, la obesidad, la edad 35-55 años y la hospitalización inicial fueron factores asociados. Los síntomas se fueron resolviendo con el transcurso del tiempo. Introdução: A doença coronavírus 2019 (COVID-19) é um problema de saúde pública em todo o mundo. Após 3 semanas do início dos sintomas, entre 10-87% dos pacientes persistem com os sintomas. O objetivo do estudo foi avaliar a persistência dos sintomas em pacientes que apresentaram COVID-19, os fatores associados e explorar a percepção dos pacientes sobre a doença. Materiais e métodos: Foi realizado um estudo transversal que incluiu 85 pacientes com diagnóstico confirmado de COVID-19, que consultaram em regime ambulatorial após a fase aguda (> 3 semanas) da doença. Resultados: O tempo médio desde o diagnóstico até a consulta ambulatorial foi de 53 dias (intervalo interquartil 31-65). A maioria (86%) apresentou quadro leve e não necessitou de internação. 45% eram mulheres e a média de idade foi de 43 anos (desvio padrão de 13). 52% (IC 95% 41-63%) dos pacientes persistiram com os sintomas além da fase aguda da doença. O sintoma que mais persistiu foi fadiga (49%) seguida de tosse (33%). 19% tinham insônia e 16%, ansiedade. Sexo feminino, obesidade, idade entre 35-55 anos e internação inicial estiveram associados à persistência dos sintomas. 20% dos pacientes deixaram de seguir as recomendações de prevenção por acreditarem que estavam imunizados. Conclusão: Mais da metade dos pacientes persistiu com os sintomas 3 semanas após o diagnóstico de COVID-19. Sexo feminino, obesidade, idade de 35-55 anos e hospitalização inicial são fatores associados. Os sintomas desapareceram com o tempo. Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2021-03-17 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion application/pdf text/html https://revistas.unc.edu.ar/index.php/med/article/view/32048 Revista de la Facultad de Ciencias Médicas de Córdoba.; Vol. 78 No. 1 (2021); 33-36 Revista de la Facultad de Ciencias Médicas de Córdoba; Vol. 78 Núm. 1 (2021); 33-36 Revista da Faculdade de Ciências Médicas de Córdoba; v. 78 n. 1 (2021); 33-36 1853-0605 0014-6722 10.31053/1853.0605.v78.n1 spa https://revistas.unc.edu.ar/index.php/med/article/view/32048/33292 https://revistas.unc.edu.ar/index.php/med/article/view/32048/33268 Derechos de autor 2021 Universidad Nacional de Córdoba http://creativecommons.org/licenses/by-nc/4.0 |